BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yang X, Peng P, Zhang L. Multiline treatment of advanced squamous cell carcinoma of the lung: A case report and review of the literature. World J Clin Cases 2019; 7(14): 1899-1907 [PMID: 31417937 DOI: 10.12998/wjcc.v7.i14.1899]
URL: https://www.wjgnet.com/2307-8960/full/v7/i14/1899.htm
Number Citing Articles
1
Endostatin/vinorelbineReactions Weekly 2020; 1785(1): 207 doi: 10.1007/s40278-020-73188-6
2
Chen Yang, Rui Zeng, Yawen Zha, Yani Li, Ting Wang, Ruolan Zhao, Minying Li, Jingjing Zhang. Case report: Clinical complete response in advanced ALK-positive lung squamous cell carcinoma: a case study of successful anti-PD-1 immunotherapy post ALK-TKIs failureFrontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1360671
3
Bin Yao, Xue Han, Linrong Pang, Caihong Xu, Sisi Liu, Xiaochun Cheng, Jun Chen. Acquired ALK Resistance Mutations Identified from Liquid Biopsy in an ALK-Rearranged Squamous Cell Lung Cancer Patient Treated with Sequential ALK TKI Therapy: A Case ReportOncoTargets and Therapy 2021; : 4329 doi: 10.2147/OTT.S315832
4
Denggang Fu, Biyu Zhang, Lei Yang, Shaoxin Huang, Wang Xin. Development of an Immune-Related Risk Signature for Predicting Prognosis in Lung Squamous Cell CarcinomaFrontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00978